Cargando…
Evaluation of Adverse Reactions to Influenza Vaccination: A Prospective Cohort Study
This study aimed to investigate the influence of sex, age, and quadrivalent vaccination history on adverse reactions (ARs) to influenza vaccines and the relationship between the occurrence of ARs and the risk of influenza infection. Study participants were employees of three hospitals in the Hyogo P...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610483/ https://www.ncbi.nlm.nih.gov/pubmed/36298529 http://dx.doi.org/10.3390/vaccines10101664 |
_version_ | 1784819280643096576 |
---|---|
author | Kumabe, Ayako Kenzaka, Tsuneaki Yahata, Shinsuke Goda, Ken Okayama, Masanobu |
author_facet | Kumabe, Ayako Kenzaka, Tsuneaki Yahata, Shinsuke Goda, Ken Okayama, Masanobu |
author_sort | Kumabe, Ayako |
collection | PubMed |
description | This study aimed to investigate the influence of sex, age, and quadrivalent vaccination history on adverse reactions (ARs) to influenza vaccines and the relationship between the occurrence of ARs and the risk of influenza infection. Study participants were employees of three hospitals in the Hyogo Prefecture, Japan, who received the influenza vaccine in 2019. Data were collected using questionnaires. The main factors were age, sex, and history of influenza vaccination as a control. The primary outcomes were the incidence of local and systemic ARs attributable to the vaccine and positive influenza cases among the participants during the influenza season. Logistic regression was used to calculate the odds ratio (OR) and 95% confidence interval (CI). Among the 1493 participants, 80% experienced either local or systemic ARs. ARs were less common among men than among women (OR: 0.28, 95% CI: 0.21–0.37) and less common among those aged ≥60 years (OR: 0.48, 95% CI: 0.26–0.89). ARs were significantly more likely to occur in those with a history of influenza vaccination (OR: 1.96, 95% CI: 1.15–3.33). Those who had ARs, notably localized ones, were significantly more likely to incur influenza infection. Individuals who report ARs to influenza vaccination should strictly adopt non-pharmaceutical preventive measures in the hospital, community settings, and at home. |
format | Online Article Text |
id | pubmed-9610483 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96104832022-10-28 Evaluation of Adverse Reactions to Influenza Vaccination: A Prospective Cohort Study Kumabe, Ayako Kenzaka, Tsuneaki Yahata, Shinsuke Goda, Ken Okayama, Masanobu Vaccines (Basel) Article This study aimed to investigate the influence of sex, age, and quadrivalent vaccination history on adverse reactions (ARs) to influenza vaccines and the relationship between the occurrence of ARs and the risk of influenza infection. Study participants were employees of three hospitals in the Hyogo Prefecture, Japan, who received the influenza vaccine in 2019. Data were collected using questionnaires. The main factors were age, sex, and history of influenza vaccination as a control. The primary outcomes were the incidence of local and systemic ARs attributable to the vaccine and positive influenza cases among the participants during the influenza season. Logistic regression was used to calculate the odds ratio (OR) and 95% confidence interval (CI). Among the 1493 participants, 80% experienced either local or systemic ARs. ARs were less common among men than among women (OR: 0.28, 95% CI: 0.21–0.37) and less common among those aged ≥60 years (OR: 0.48, 95% CI: 0.26–0.89). ARs were significantly more likely to occur in those with a history of influenza vaccination (OR: 1.96, 95% CI: 1.15–3.33). Those who had ARs, notably localized ones, were significantly more likely to incur influenza infection. Individuals who report ARs to influenza vaccination should strictly adopt non-pharmaceutical preventive measures in the hospital, community settings, and at home. MDPI 2022-10-06 /pmc/articles/PMC9610483/ /pubmed/36298529 http://dx.doi.org/10.3390/vaccines10101664 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kumabe, Ayako Kenzaka, Tsuneaki Yahata, Shinsuke Goda, Ken Okayama, Masanobu Evaluation of Adverse Reactions to Influenza Vaccination: A Prospective Cohort Study |
title | Evaluation of Adverse Reactions to Influenza Vaccination: A Prospective Cohort Study |
title_full | Evaluation of Adverse Reactions to Influenza Vaccination: A Prospective Cohort Study |
title_fullStr | Evaluation of Adverse Reactions to Influenza Vaccination: A Prospective Cohort Study |
title_full_unstemmed | Evaluation of Adverse Reactions to Influenza Vaccination: A Prospective Cohort Study |
title_short | Evaluation of Adverse Reactions to Influenza Vaccination: A Prospective Cohort Study |
title_sort | evaluation of adverse reactions to influenza vaccination: a prospective cohort study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610483/ https://www.ncbi.nlm.nih.gov/pubmed/36298529 http://dx.doi.org/10.3390/vaccines10101664 |
work_keys_str_mv | AT kumabeayako evaluationofadversereactionstoinfluenzavaccinationaprospectivecohortstudy AT kenzakatsuneaki evaluationofadversereactionstoinfluenzavaccinationaprospectivecohortstudy AT yahatashinsuke evaluationofadversereactionstoinfluenzavaccinationaprospectivecohortstudy AT godaken evaluationofadversereactionstoinfluenzavaccinationaprospectivecohortstudy AT okayamamasanobu evaluationofadversereactionstoinfluenzavaccinationaprospectivecohortstudy |